APA
Koch T., Dahlke C., Fathi A., Kupke A., Krähling V., Okba N. M. A., Halwe S., Rohde C., Eickmann M., Volz A., Hesterkamp T., Jambrecina A., Borregaard S., Ly M. L., Zinser M. E., Bartels E., Poetsch J. S. H., Neumann R., Fux R., Schmiedel S., Lohse A. W., Haagmans B. L., Sutter G., Becker S. & Addo M. M. (20200909). Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. : The Lancet. Infectious diseases.
Chicago
Koch Till, Dahlke Christine, Fathi Anahita, Kupke Alexandra, Krähling Verena, Okba Nisreen M A, Halwe Sandro, Rohde Cornelius, Eickmann Markus, Volz Asisa, Hesterkamp Thomas, Jambrecina Alen, Borregaard Saskia, Ly My L, Zinser Madeleine E, Bartels Etienne, Poetsch Joseph S H, Neumann Reza, Fux Robert, Schmiedel Stefan, Lohse Ansgar W, Haagmans Bart L, Sutter Gerd, Becker Stephan and Addo Marylyn M. 20200909. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. : The Lancet. Infectious diseases.
Harvard
Koch T., Dahlke C., Fathi A., Kupke A., Krähling V., Okba N. M. A., Halwe S., Rohde C., Eickmann M., Volz A., Hesterkamp T., Jambrecina A., Borregaard S., Ly M. L., Zinser M. E., Bartels E., Poetsch J. S. H., Neumann R., Fux R., Schmiedel S., Lohse A. W., Haagmans B. L., Sutter G., Becker S. and Addo M. M. (20200909). Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. : The Lancet. Infectious diseases.
MLA
Koch Till, Dahlke Christine, Fathi Anahita, Kupke Alexandra, Krähling Verena, Okba Nisreen M A, Halwe Sandro, Rohde Cornelius, Eickmann Markus, Volz Asisa, Hesterkamp Thomas, Jambrecina Alen, Borregaard Saskia, Ly My L, Zinser Madeleine E, Bartels Etienne, Poetsch Joseph S H, Neumann Reza, Fux Robert, Schmiedel Stefan, Lohse Ansgar W, Haagmans Bart L, Sutter Gerd, Becker Stephan and Addo Marylyn M. Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial. : The Lancet. Infectious diseases. 20200909.